Photosensitive AIEgens sensitize bacteria to oxidative damage and modulate the inflammatory responses of macrophages to salvage the photodynamic therapy against MRSA
Source abstract
Abstract
The urgent need for antimicrobial agents to combat infections caused by multidrug-resistant bacteria facilitates the exploration of alternative strategies such as photosensitizer (PS)-mediated photoinactivation. However, increasing studies have discovered uncorrelated bactericidal activities among PSs possessing similar photodynamic and pathogen-targeted properties. To optimize the photodynamic therapy (PDT) against infections, we investigated three type-I PSs of D-π-A AIEgens TI, TBI, and TTI. The capacities of reactive oxygen species (ROS) generation of TI, TBI, and TTI did not align with their bactericidal activities. Despite exhibiting the lowest photodynamic efficiency, TI exhibited the highest activities against methicillin-resistant Staphylococcus aureus (MRSA) by impairing the anti-oxidative responses of bacteria. By comparison, TTI, characterized by the strongest ROS production, inactivated intracellular MRSA by potentiating the inflammatory response of macrophages. Unlike TI and TTI, TBI, despite possessing moderate photodynamic activities and inducing ROS accumulation in both MRSA and macrophages, did not exhibit any antibacterial activity. Therefore, relying on the disturbed anti-oxidative metabolism of pathogens or potentiated host immune responses, transient ROS bursts can effectively control bacterial infections. Our study reevaluates the contribution of photodynamic activities of PSs to bacterial elimination and provides new insights into discovering novel antibacterial targets and agents.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Photodynamic Therapy Research Studies · Nanoplatforms for cancer theranostics · Antimicrobial Peptides and Activities
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (59)
Show source-provided references
1. The post-antibiotic era is here10.1126/science.abl5997 ↗
2. The antibiotic resistome: a Guide for the discovery of natural products as antimicrobial agents10.1021/acs.chemrev.0c01214 ↗
3. Environmental factors influencing the development and spread of antibiotic resistance10.1093/femsre/fux053 ↗
4. Return of the Trojan horse: intracellular phenotype switching and immune evasion by Staphylococcus aureus10.1002/emmm.201100123 ↗
5. The re-emergence of natural products for drug discovery in the genomics era10.1038/nrd4510 ↗
6. Multifunctional photoactive hydrogels for wound healing acceleration10.1021/acsnano.1c08334 ↗
7. Oxidative stress, protein damage and repair in bacteria10.1038/nrmicro.2017.26 ↗
8. Natural diversity in heat resistance of bacteria and bacterial spores: impact on food safety and quality10.1146/annurev-food-030117-012808 ↗
9. Aggregation‐enhanced theranostics: AIE sparkles in biomedical field10.1002/agt2.7 ↗
10. Molecular mechanism of aggregation‐induced emission10.1002/agt2.91 ↗
11. Theranostic applications of biomolecule‐responsive aggregation‐induced emission luminogens
12. Efficient killing of multidrug-resistant internalized bacteria by AIEgens in vivo
13. Double-pronged antimicrobial agents based on a donor-p-acceptor type aggregation-induced emission luminogen10.1002/anie.202212386 ↗
14. The thioredoxin antioxidant system10.1016/j.freeradbiomed.2013.07.036 ↗
15. Small-molecule targeting of a diapophytoene desaturase inhibits S. aureus virulence10.1038/nchembio.2003 ↗
16. Staphylococcus aureus, phagocyte NADPH oxidase and chronic granulomatous disease
17. A protein-free vaccine stimulates innate immunity and protects against nosocomial pathogens10.1126/scitranslmed.adf9556 ↗
18. PD-1/PD-L1 blockade is a potent adjuvant in treatment of Staphylococcus aureus osteomyelitis in mice10.1016/j.ymthe.2022.09.006 ↗
19. Berbamine promotes macrophage autophagy to clear Mycobacterium tuberculosis by regulating the ROS/Ca(2+) axis
20. Myeloperoxidase targets oxidative host attacks to Salmonella and prevents collateral tissue damage10.1038/nmicrobiol.2016.268 ↗
21. SIRT3 promotes antimycobacterial defenses by coordinating mitochondrial and autophagic functions10.1080/15548627.2019.1582743 ↗
22. Full-coverage regulations of autophagy by ROS: from induction to maturation10.1080/15548627.2021.1984656 ↗
23. Brightness and shadows of mitochondrial ROS in the brain10.1016/j.nbd.2023.106199 ↗
24. Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production10.1074/jbc.M210432200 ↗
25. Inhibition of mitophagy drives macrophage activation and antibacterial defense during sepsis10.1172/JCI130996 ↗
26. Telomeres and mitochondrial metabolism: Implications for cellular senescence and age-related diseases10.1007/s12015-022-10370-8 ↗
27. Immunometabolic crosstalk during bacterial infection10.1038/s41564-022-01080-5 ↗
28. The IRE1alpha-XBP1 signaling axis promotes glycolytic reprogramming in response to inflammatory stimuli10.1128/mbio.03068-22 ↗
29. A red emitting mitochondria-targeted AIE probe as an indicator for membrane potential and mouse sperm activity10.1039/C5CC04731E ↗
30. Zwitterionic AIEgens: rational molecular design for NIR-II fluorescence imaging-guided synergistic phototherapy10.1002/adfm.202007026 ↗
31. Beta-galactoside transport in bacterial membrane preparations: energy coupling via membrane-bounded D-lactic dehydrogenase10.1073/pnas.66.4.1190 ↗
32. Localization of acid and alkaline phosphatases in Staphylococcus aureus10.1111/j.1348-0421.1974.tb00812.x ↗
33. Heterogeneous resistance to vancomycin in Staphylococcus epidermidis, Staphylococcus haemolyticus and Staphylococcus warneri clinical strains: characterisation of glycopeptide susceptibility profiles and cell wall thickening10.1016/j.ijantimicag.2005.11.013 ↗
34. The bacterial cytoplasm has glass-like properties and is fluidized by metabolic activity10.1016/j.cell.2013.11.028 ↗
35. Reversible induction of ATP synthesis by DNA damage and repair in Escherichia coli. In vivo NMR studies10.1074/jbc.273.46.30232 ↗
36. Transcriptional responses to DNA damage10.1016/S1369-5274(00)00186-7 ↗
37. Effects of antibacterial mineral leachates on the cellular ultrastructure, morphology, and membrane integrity of Escherichia coli and methicillin-resistant Staphylococcus aureus10.1186/1476-0711-9-26 ↗
38. Inactivation of Staphylococcus aureus by photodynamic action of hypocrellin B10.1016/j.pdpdt.2013.06.004 ↗
39. Laser impact on bacterial ATP: insights into the mechanism of laser-bacteria interactions10.1080/0892701021000028488 ↗
40. Why do fast-growing bacteria enter overflow metabolism? Testing the membrane real estate hypothesis10.1016/j.cels.2017.06.005 ↗
41. Variable staphyloxanthin production by Staphylococcus aureus drives strain-dependent effects on diabetic wound-healing outcomes10.1016/j.celrep.2023.113281 ↗
42. Staphylococcal biofilm development: structure, regulation, and treatment strategies10.1128/MMBR.00026-19 ↗
43. Mini-review: biofilm responses to oxidative stress10.1080/08927014.2015.1134515 ↗
44. Staphylococcus aureus extracellular vesicles induce apoptosis and restrain mitophagy-mediated degradation of damaged mitochondria10.1016/j.micres.2023.127421 ↗
45. Vascular endothelial cell development and diversity10.1038/s41569-022-00770-1 ↗
46. Basic colorimetric proliferation assays: MTT, WST, and resazurin10.1007/978-1-4939-6960-9_1 ↗
47. Cell sensitivity assays: the MTT assay10.1007/978-1-61779-080-5_20 ↗
48. NAD(H) and NADP(H) redox couples and cellular energy metabolism10.1089/ars.2017.7216 ↗
49. AIE-based theranostic systems for detection and killing of pathogens10.7150/thno.31844 ↗
50. Menadione (vitamin K) enhances the antibiotic activity of drugs by cell membrane permeabilization mechanism10.1016/j.sjbs.2015.09.004 ↗
51. Mitochondrial function in the human oocyte and embryo and their role in developmental competence10.1016/j.mito.2010.09.012 ↗
52. Cellular mitophagy: mechanism, roles in diseases and small molecule pharmacological regulation10.7150/thno.79876 ↗
53. Listeria hijacks host mitophagy through a novel mitophagy receptor to evade killing10.1038/s41590-019-0324-2 ↗
54. Mitochondria in the regulation of innate and adaptive immunity10.1016/j.immuni.2015.02.002 ↗
55. Structure and mechanisms of F-type ATP Synthases10.1146/annurev-biochem-013118-110903 ↗
56. How the regulatory protein, IF(1), inhibits F(1)-ATPase from bovine mitochondria10.1073/pnas.0707326104 ↗
57. Up-regulation of the ATPase inhibitory factor 1 (IF1) of the mitochondrial H+-ATP synthase in human tumors mediates the metabolic shift of cancer cells to a Warburg phenotype10.1074/jbc.M110.146480 ↗
58. Novel treatment strategies for biofilm-based infections10.1007/s40265-019-01184-z ↗
59. Host-directed therapies for bacterial and viral infections10.1038/nrd.2017.162 ↗